Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_assertion description "[Clinical trials demonstrated that JAK1/2 inhibitors ameliorate constitutional symptoms and reduce spleen size in patients with myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_assertion evidence source_evidence_literature NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_assertion SIO_000772 23313046 NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_assertion wasDerivedFrom befree-20150227 NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_assertion wasGeneratedBy ECO_0000203 NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP519011.RAlxlo3ZNsJOWU6CyOJGil04DJKQZLSGinmdHOEPHkHTs130_provenance.